Ellen A. A. van der Plas
Associate Professor
Also affiliated: Leiden University (2008); California Institute of Technology (2011); University of Iowa (2008–2024); Arkansas Children's Hospital (2023–2026); Harvard University (2011); University of Toronto (2016); University of Washington (2011); Glasgow Royal Infirmary (2022); Hospital for Sick Children (2013–2017); University of Iowa Hospitals and Clinics (2010–2024); Massachusetts General Hospital (2011); University of Iowa Stead Family Children’s Hospital (2019); University of Iowa Health Care (2020–2024); Queen Elizabeth University Hospital (2020); Arkansas Children's Research Institute (2023–2026); University of Glasgow (2020–2021)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ellen A. A. van der Plas's research focuses on neurodevelopmental changes and cognitive function, particularly in vulnerable populations. She has investigated executive control deficits in individuals with substance dependence, comparing different substances and genders. Her work also examines abnormal brain development in young individuals carrying genetic mutations associated with Huntington's disease, exploring how these genetic factors impact neurological development from childhood through adolescence.
Further research by van der Plas explores cognitive impairment in survivors of pediatric acute lymphoblastic leukemia, specifically looking at the effects of chemotherapy treatments on brain structure and cognitive abilities like working memory and response inhibition. She has also studied the relationship between amygdala volume and fearfulness in healthy adolescent girls, contributing to an understanding of individual differences in emotional processing during development. Van der Plas leads a research group and is recognized as a highly cited researcher, with a notable publication record and significant citation counts.
Metrics
- h-index: 22
- Publications: 86
- Citations: 1,583
Positions
-
Associate Professor 2022–presentUniversity of Arkansas for Medical Sciences Pediatrics ORCID
-
Associate Professor 2022–presentArkansas Children’s Hospital Research Institute Hematology/Oncology ORCID
-
Research Assistant Professor 2017–2022University of Iowa Hospitals and Clinics Psychiatry ORCID
-
Research Fellow 2012–2017Hospital for Sick Children Psychiatry ORCID
Selected Publications
-
Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury (2026)
-
Feasibility of Non-Sedated Multispectral Neuroimaging in Newly Diagnosed Children with Leukemia (2026)
-
A supervised STreNgth & Outpatient Exercise Regimen in pediatric patients with Acute Lymphoblastic Leukemia (STRONGER ALL) (2026)
-
Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease (2025)
-
Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis (2025)
-
Central Nervous System Iron Content in Pediatric CKD (2025)
-
Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
An Activation Likelihood Estimation Meta-Analysis of Voxel-Based Morphometry Studies of Chemotherapy-Related Brain Volume Changes in Breast Cancer (2025)
-
A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects (2025)
-
130 A supervised strength and outpatient exercise regimen in pediatric patients with acute lymphoblastic leukemia (STRONGER ALL) (2025)
-
Age-Related Changes in Brain Structure in Pediatric Chronic Kidney Disease (2025)
-
A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects (2024)
-
Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia (2024)
-
Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study (2024)
Collaboration Network
Top Collaborators
- Neurocognitive deficits may not resolve following pediatric kidney transplantation
- Understanding the impact of pediatric kidney transplantation on cognition: A review of the literature
- Age-Related Changes in Brain Structure in Pediatric Chronic Kidney Disease
- Central Nervous System Iron Content in Pediatric CKD
- Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury
- Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1
- Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Feasibility of Non-Sedated Multispectral Neuroimaging in Newly Diagnosed Children with Leukemia
- Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- Central Nervous System Iron Content in Pediatric CKD
- Neurocognitive deficits may not resolve following pediatric kidney transplantation
- Central Nervous System Iron Content in Pediatric CKD
- Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury
- Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
- Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia
- Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study
- Neurocognitive deficits may not resolve following pediatric kidney transplantation
- Understanding the impact of pediatric kidney transplantation on cognition: A review of the literature
- Neurocognitive deficits may not resolve following pediatric kidney transplantation
- Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury
- Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1
- Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury
- Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
- Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study
- Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
- Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
- A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects
- A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects
Similar Researchers
Based on overlapping research topics